Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
12/13/2007 | WO2007141473A1 N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl] -l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors |
12/13/2007 | WO2007141253A1 Process for the production of intermediates for the preparation of tricyclic imidazopyridines |
12/13/2007 | WO2007140934A1 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof |
12/13/2007 | WO2007140894A1 5-aryl-substituted dihydropyridopyrimidines and dihydropyridazines and use thereof as mineral corticoid antagonists |
12/13/2007 | WO2007120590A3 Process for the preparation of pyridine heterocycle cgrp antagonist intermediate |
12/13/2007 | WO2007111904A3 C-met protein kinase inhibitors for the treatment of proliferative disorders |
12/13/2007 | WO2007105154A3 Antibiotic compounds |
12/13/2007 | WO2006078575A3 Fluorinated aminoalkyl-4-oxo-3,4-dihydropyrido[3,4- d] pyrimidines as inhibitors of mitotic kinesins |
12/13/2007 | WO2006074281A3 Inhibitors of checkpoint kinases |
12/13/2007 | WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
12/13/2007 | US20070287838 Imidazo[4,5-B]Pyridin-2-One and Oxazolo[4,5-B]Pyridin-2-One Compounds and Analogs Thereof as Therapeutic Compounds |
12/13/2007 | US20070287726 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines |
12/13/2007 | US20070287725 Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Compounds And Method |
12/13/2007 | US20070287724 Substituted Imidazoquinolines, Imidazopyridines, and Imidazonaphthyridines |
12/13/2007 | US20070287723 2-alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9h-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents |
12/13/2007 | US20070287721 Pyrazolopyridinyl pyridine |
12/13/2007 | US20070287711 Fused ring heterocycle kinase modulators |
12/13/2007 | US20070287701 6-({[(1-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]amino}methyl)-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
12/13/2007 | US20070287700 Polycyclic agents for the treatment of respiratory syncytial virus infections |
12/13/2007 | US20070287699 Antiviral agents |
12/13/2007 | DE102006026585A1 Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung Substituted-4-aryl-1,4-dihydro-1,6-naphthyridines and their use |
12/13/2007 | DE102006026583A1 Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung Aryl-substituted hetero-bicyclic compounds and their use |
12/13/2007 | CA2654445A1 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
12/13/2007 | CA2654147A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
12/13/2007 | CA2651550A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase |
12/12/2007 | EP1864984A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
12/12/2007 | EP1864982A1 Triamine derivative |
12/12/2007 | EP1863880A2 Fluoroquinolonoquinolones and inkjet ink compositions comprising the same |
12/12/2007 | EP1863820A1 Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases |
12/12/2007 | EP1863819A2 Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors |
12/12/2007 | EP1863818A1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
12/12/2007 | EP1863814A1 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
12/12/2007 | EP1863813A2 Pyrazolo[3,4-c]quinolines, pyrazolo[3,4-c]naphthyridines, analogs thereof, and methods |
12/12/2007 | EP1863812A1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
12/12/2007 | EP1863811A1 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
12/12/2007 | EP1863810A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1' RECEPTOR LIGANDS |
12/12/2007 | EP1863809A2 Pyrazolopyridines and analogs thereof |
12/12/2007 | EP1863808A1 Gaboxadol forms, compositions thereof, and related methods |
12/12/2007 | EP1863792A1 Atp competitive kinase inhibitors |
12/12/2007 | EP1863776A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
12/12/2007 | EP1863770A2 Ring closing and related methods and intermediates |
12/12/2007 | EP1863483A1 Bicyclic pyrazole compounds as antibacterial agents |
12/12/2007 | EP1732935B1 Lanthanide chelates and use thereof in bioanalysis |
12/12/2007 | EP1682545B1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
12/12/2007 | EP1442133B1 Use of Mirtazapine for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
12/12/2007 | EP1399443B1 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
12/12/2007 | CN101087789A Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
12/12/2007 | CN101087788A Quinoline derivative, its use, production and pharmaceutical agents containing the latter |
12/12/2007 | CN101087787A Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents |
12/12/2007 | CN101087786A Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents |
12/12/2007 | CN101087782A (2-carboxamido)(3-amino) thiophene compounds |
12/12/2007 | CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
12/12/2007 | CN100354275C Pyrazolopyridine derivates |
12/12/2007 | CN100354274C Medicines for prevention and treatment of neurodegenerative diseases |
12/11/2007 | US7307170 Epindolidione pigments |
12/11/2007 | US7307168 Process for the preparation of 3-{2-′4- (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyllethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido′1,2-methyl-4h-pyrido′,2-a!pyrimidin-4-one |
12/11/2007 | US7307165 Process for producting imidazo[1,2-b]pyridazine derivative |
12/11/2007 | US7307088 Substituted anthranilic amide derivatives and methods of use |
12/11/2007 | US7307086 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
12/11/2007 | US7307085 Mitotic kinesin inhibitors |
12/11/2007 | US7307084 Gastric secretion inhibiting and excellent gastric and intestinal protective action properties, gastrointestinal disorder |
12/11/2007 | US7307082 Heterocyclic derivatives as CRF antagonists |
12/11/2007 | US7307074 Diazepan derivatives or salts thereof |
12/11/2007 | CA2413510C Condensed pyrazindione derivatives |
12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
12/06/2007 | WO2007139813A1 Imidazoazephinone compounds |
12/06/2007 | WO2007139724A1 2,5-di(methoxyanilino)terephthalic acid polymorphs and quinacridones realized therefrom |
12/06/2007 | WO2007138974A1 Novel heterocyclic compound or salt thereof and intermediate thereof |
12/06/2007 | WO2007138408A1 11c/18 f-labeled inhibitors of glycogen synthase kinase-3 |
12/06/2007 | WO2007138081A1 PYRIMIDINO[1',6'-1,2]PYRIDO[3,4-b]INDOLE DERIVATIVES AND THEIR THERAPEUTIC USAGE |
12/06/2007 | WO2007138051A1 Dibenzorylenetetracarboximides as infrared absorbers |
12/06/2007 | WO2007138041A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
12/06/2007 | WO2007138040A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
12/06/2007 | WO2007138039A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use |
12/06/2007 | WO2007138038A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
12/06/2007 | WO2007138037A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
12/06/2007 | WO2007138033A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
12/06/2007 | WO2007137954A1 Aryl-4-ethynyl-isoxazole derivatives |
12/06/2007 | WO2007137820A1 PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM |
12/06/2007 | WO2007137819A1 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM |
12/06/2007 | WO2007137801A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydro-imidazopyridine and tetrahydrotriazolopyridine derivatives and use thereof |
12/06/2007 | WO2007137793A1 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
12/06/2007 | WO2007137738A1 Spirocyclic nitriles as protease inhibitors |
12/06/2007 | WO2007115315A3 Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
12/06/2007 | WO2007084667A3 Fused heterobicyclic kinase inhibitors |
12/06/2007 | US20070282107 Reacting n-protected-3-cyano-4-oxo-pyrrolidine with with alkoxyamine or haloalkoxyamine in the presence of a base, reacting with methanesulfonic acid, adding methanesulfonic acid and hydrogenation catalyst, hydrogenation reaction |
12/06/2007 | US20070282106 reacting 1-phenyl-3-carbonyl-6-(p-(2-pyridon-1-yl)phenyl-4,5-dihydro-pyrazolo[3,4-c]pyrid-2-one derivatives with a Grignard reagent CH3MgCl; hydroxylation; useful as factor Xa inhibitors |
12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
12/06/2007 | US20070281965 modulators of GABAA receptors comprising deuterated analogs of zolpidem, used for the treatment and management of sleep disorders, and/or for providing a patient in need with a hypnotic, anxiolytic or anticonvulsive effect |
12/06/2007 | US20070281963 tyrosine kinase inhibitors such as 3-amino-2-(2-chloro-5-hydroxyphenyl)-7-(3-morpholin-4-ylpropoxy)-2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one, used as anticarcinogenic or antiproliferative agents |
12/06/2007 | US20070281962 Administering 1,2,3,6-tetrasubstituted pyrido[3,4-b]indoles to inhibit the 5'-untranslated region-dependent translation; anticarcinogenic agents; retinopathy, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, macular degeneration |
12/06/2007 | US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists |
12/06/2007 | US20070281950 1-((6-chloropyridin-3-yl)methyl)-8-nitro-1,2,3,5,6,7-hexahydro imidazo[1,2-a]pyridin-5-ol; 1-((6-chloropyridin-3-yl)methyl)-5-methoxy-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; increased photostability and liposolubility |
12/06/2007 | US20070281942 Glucokinase activators |
12/06/2007 | US20070281928 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |
12/06/2007 | US20070280971 Phosphodiesterase type IV (PDE4) inhibitor; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide; inflammatory and/or allergic diseases such as atopic dermatitis |
12/06/2007 | DE102006025318A1 Dihydro-pyrrolopyridin-, Dihydro-pyrrolopyridazin- und Dihydro-pyrrolopyrimidin-Derivate und ihre Verwendung Dihydro-pyrrolopyridin-, dihydro-pyrrolopyridazin- and dihydro-pyrrolopyrimidine derivatives and their use |
12/06/2007 | DE102006025315A1 Tetrahydro-pyrrolopyridin-, Tetrahydro-pyrazolopyridin-, Tetrahydro-imidazopyridin- und Tetrahydro-triazolopyridin-Derivate und ihre Verwendung Tetrahydro-pyrrolopyridin-, tetrahydro-pyrazolopyridin-, tetrahydro-imidazopyridine and tetrahydro-triazolopyridine derivatives and their use |
12/06/2007 | CA2653818A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |